Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q2 2025 Earnings Call Transcript August 7, 2025
Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.46 EPS, expectations were $-0.44.
Operator: Good morning. My name is John, and I’ll be your conference operator today. At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals Second Quarter Earnings Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the...
